Sars
📧 Sign up to get email alerts when something new happens for Sars.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults. [Phase 1, Phase 2]
A Phase 1/2 dose-finding trial evaluating the safety, reactogenicity, and immune response of GBP511, a broadly protective sarbecovirus vacci…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial [Phase 2, Phase 3]
The SNOW trial evaluating a nasal/pharyngeal and oral pharyngeal wash for SARS-CoV-2/COVID-19 is currently active but not recruiting for Pha…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults [Phase 2]
This is a Phase 2 clinical trial update evaluating the safety and effects of the RNA vaccine ARCT-021 in healthy adults. The study was termi…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa [Phase 1]
Phase 1 study evaluating VXCO-100, a SARS-CoV candidate vaccine, in adults in South Africa has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States [Phase 1]
Phase 1 trial update for VXCO-100, a SARS-CoV candidate vaccine, conducted in healthy adults in the United States; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: [Phase 3]
A Phase 3 trial evaluating montelukast for mild-to-moderate respiratory symptoms in long-COVID-19 has been terminated.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
This ClinicalTrials.gov entry describes the COVITRA study, a recruiting investigation into the prevalence and outcomes of SARS-CoV-2 infecti…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19
A clinical trial update about studying immune cells in inflammatory arthritis in the context of coronaviruses (including SARS and COVID-19),…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine [Phase 3]
Phase 3 trial update reporting immunogenicity, efficacy and safety data for the QazCovid-in COVID-19 vaccine.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating fostamatinib for COVID-19 has completed enrollment and study status.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Cyclosporine For The Treatment Of COVID-19(+) [Phase 2]
Clinical trial update on cyclosporine for COVID-19 positive patients in Phase 2, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 [Phase 2, Phase 3]
Phase 2/3 trial on safety and efficacy of hyperbaric oxygen for ARDS in COVID-19 patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: Sisonke (Together): OPEN LABEL TRIAL COVID-19 [Phase 3]
Open-label Phase 3 COVID-19 trial (Sisonke) has completed enrollment and status is completed.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. [Phase 3]
A Phase 3 trial assessing whether vitamin D treatment reduces mortality in SAR/SARS pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 [Phase 2]
Phase 2 protocol design update for evaluating immunity from bivalve fluids in coronavirus infections including SARS and COVID-19.
-
CLINICAL_TRIALS withdrawal · 2022-03-04Clinical Trial Update: Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit [Phase 3]
A Phase 3 trial of proxalutamide for COVID-19 in ICU settings was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Proxalutamide Treatment for Hospitalized COVID-19 Patients [Phase 3]
Phase 3 trial update for proxalutamide in hospitalized COVID-19 patients; trial completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan [Phase 1, Phase 2]
Clinical trial update on prophylaxis for COVID-19 in healthcare workers using intensive treatment with ivermectin and iota-carrageenan (Phas…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Low Dose Radiotherapy in COVID-19 Pneumonia [Phase 1, Phase 2]
Clinical trial update for low dose radiotherapy in COVID-19 pneumonia, covering Phase 1 and Phase 2 investigations.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 [Phase 3]
Phase 3 randomized double-blind study evaluating oral polio vaccine and NA-831 for COVID-19 is ongoing with unknown status.